0.04Open0.05Pre Close1 Volume47 Open Interest70.00Strike Price4.00Turnover88.34%IV13.53%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type-0.0187Delta0.0080Gamma2022.75Leverage Ratio-0.0357Theta-0.0001Rho-37.81Eff Leverage0.0030Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet